The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins

被引：95

作者：

Zhu, WQ ^{[1
]}

Sano, H ^{[1
]}

Nagai, R ^{[1
]}

Fukuhara, K ^{[1
]}

Miyazaki, A ^{[1
]}

Horiuchi, S ^{[1
]}

机构：

[1] Kumamoto Univ, Sch Med, Dept Biochem, Kumamoto 8600811, Japan

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2001年 / 280卷 / 04期

关键词：

galectin-3; AGE; AGE-receptors; scavenger receptor class A (SR-A); modified LDLs; foam cells; atherosclerosis;

D O I：

10.1006/bbrc.2001.4256

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Galectin-3, a member of beta -galactoside-binding lectin family, is suggested to be an AGE-receptor. To examine this possibility, we prepared CHO cells overexpressing human galectin-3 (galectin-3-CHO cells). Galectin-3-CHO cells showed a specific and saturable binding to I-125-AGE-BSA with Kd of 3.1 mug/ml. I-125-AGE-BSA was endocytosed by galectin-3-CHO cells and underwent lysosomal degradation. The endocytosis of I-125-AGE-BSA was inhibited not only by unlabeled AGE-BSA but also by acetylated LDL and oxidized LDL, ligands for the scavenger receptor family. Furthermore, I-125-oxidized LDL and I-125-acetylated LDE were actively endocytosed by galectin-3-CHO cells and the incubation with acetyl-LDL led to intracellular accumulation of cholesteryl esters, indicating the role of galectin-3 in endocytosis of AGE-proteins and modified LDLs. Since galectin-3 was localized and upregulated in foam cells at human atherosclerotic lesions, the present results suggest that galectin-3 plays an important role in formation of atherosclerotic lesions in vivo, by modulating endocytic uptake of AGE-proteins and modified LDLs. (C) 2001 Academic Press.

引用

页码：1183 / 1188

页数：6

共 50 条

[1] MACROPHAGE SCAVENGER RECEPTOR MEDIATES THE ENDOCYTIC UPTAKE AND DEGRADATION OF ADVANCED GLYCATION END-PRODUCTS OF THE MAILLARD REACTION [J].

ARAKI, N ;

HIGASHI, T ;

MORI, T ;

SHIBAYAMA, R ;

KAWABE, Y ;

KODAMA, T ;

TAKAHASHI, K ;

SHICHIRI, M ;

HORIUCHI, S .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 230 (02) :408-415

[2]

ARAKI N, 1992, J BIOL CHEM, V267, P10211

[3]

BARONDES SH, 1994, J BIOL CHEM, V269, P20807

[4]

DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873

[5] ENDOTHELIAL RECEPTOR-MEDIATED BINDING OF GLUCOSE-MODIFIED ALBUMIN IS ASSOCIATED WITH INCREASED MONOLAYER PERMEABILITY AND MODULATION OF CELL-SURFACE COAGULANT PROPERTIES [J].

ESPOSITO, C ;

GERLACH, H ;

BRETT, J ;

STERN, D ;

VLASSARA, H .

JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) :1387-1407

[6]

Finot P. A., 1982, Advances in Chemistry Series, V198, P91

[7] Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses [J].

Hsu, DK ;

Yang, RY ;

Pan, ZX ;

Lu, L ;

Salomon, DR ;

Fung-Leung, WP ;

Liu, FT .

AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :1073-1083

[8]

HSU DK, 1992, J BIOL CHEM, V267, P14167

[9] RECEPTOR-SPECIFIC INDUCTION OF INSULIN-LIKE GROWTH FACTOR-I IN HUMAN MONOCYTES BY ADVANCED GLYCOSYLATION END-PRODUCT MODIFIED PROTEINS [J].

KIRSTEIN, M ;

ASTON, C ;

HINTZ, R ;

VLASSARA, H .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) :439-446

[10] ADVANCED PROTEIN GLYCOSYLATION INDUCES TRANSENDOTHELIAL HUMAN MONOCYTE CHEMOTAXIS AND SECRETION OF PLATELET-DERIVED GROWTH-FACTOR - ROLE IN VASCULAR-DISEASE OF DIABETES AND AGING [J].

KIRSTEIN, M ;

BRETT, J ;

RADOFF, S ;

OGAWA, S ;

STERN, D ;

VLASSARA, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :9010-9014

← 1 2 3 4 5 →